Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATP synthase membrane subunit f, mitochondrial (ATP5MF) is a minor component of the mitochondrial ATP synthase complex, specifically part of the Fo domain, which forms the proton channel in the mitochondrial inner membrane. This enzyme complex is responsible for synthesizing ATP from ADP and inorganic phosphate using the energy stored in a transmembrane proton gradient established during oxidative phosphorylation. The ATP5MF subunit is essential for the normal function of the Fo domain and therefore for cellular energy metabolism. Genetic defects or altered regulation of ATP5MF are implicated in mitochondrial diseases and potentially in cancer and neurodegeneration[1][2][3][4][5][6][7].
Inhibition of ATP synthase proton channel (general, by drugs like oligomycin, likely targeting Fo complex, not specifically subunit f) ; Modulation of mitochondrial energy production (general, for ATP synthase inhibitors)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP synthase membrane subunit f, mitochondrial (ATP5MF).